Vanguard Group Inc Keros Therapeutics, Inc. Put Options Transaction History
Vanguard Group Inc
- $6.44 Trillion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding KROS
# of Institutions
169Shares Held
35.5MCall Options Held
574KPut Options Held
325K-
Adar1 Capital Management, LLC Austin, TX5.39MShares$93 Million8.01% of portfolio
-
Madison Avenue Partners, LP New York, NY2.71MShares$46.7 Million3.92% of portfolio
-
Black Rock Inc. New York, NY2.51MShares$43.4 Million0.0% of portfolio
-
Western Standard LLC Los Angeles, CA2.19MShares$37.8 Million10.27% of portfolio
-
Tang Capital Management LLC San Diego, CA1.42MShares$24.5 Million1.02% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $445M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...